Drug Discovery Today, Journal Year: 2022, Volume and Issue: 27(6), P. 1622 - 1638
Published: March 21, 2022
Language: Английский
Drug Discovery Today, Journal Year: 2022, Volume and Issue: 27(6), P. 1622 - 1638
Published: March 21, 2022
Language: Английский
Drug Metabolism and Pharmacokinetics, Journal Year: 2022, Volume and Issue: 44, P. 100450 - 100450
Published: Feb. 5, 2022
Language: Английский
Citations
59Journal of Nanobiotechnology, Journal Year: 2022, Volume and Issue: 20(1)
Published: Jan. 10, 2022
Acute myeloid leukemia (AML) is a malignant clonal disease of hematopoietic stem- and progenitor-cell origin. AML features massive proliferation abnormal blasts cells in the bone marrow inhibition normal hematopoiesis at onset. Exosomes containing proteins or nucleic acids are secreted by cells; they participate intercellular communication serve as key modulators hematopoiesis. The purpose this study was to investigate effects exosomes derived from mesenchymal stem (BMSCs) on regulation underlying mechanisms mediated microRNA (miRNA).Dysregulated miR-7-5p patients identified using qRT-PCR its clinical significance explored. Bioinformatic analysis revealed target gene OSBPL11 that could be regulated miR-7-5p. findings were validated dual-luciferase reporter assay western blotting. functional genes PI3K/AKT/mTOR signaling pathway identified, determined recovery assay. co-cultured with originating BMSCs overexpressing determine cell-cell Exo-miR-7-5p, well vitro vivo validation via gain- loss-of-function methods.Expression decreased cells. Overexpression curbed cellular promoted apoptosis. reversed tumorigenic properties vitro. Exo-miR-7-5p induced formation prone apoptosis low survival rate, expression inhibited through pathway. exhibited tumor homing vivo, development.Exo-miR-7-5p negatively regulates suppressing phosphorylation pathway, thereby inhibiting promoting data will inform development therapies based BMSC-derived exosomes.
Language: Английский
Citations
58European Journal of Nuclear Medicine and Molecular Imaging, Journal Year: 2022, Volume and Issue: 49(8), P. 2682 - 2692
Published: Feb. 11, 2022
Language: Английский
Citations
56Chemical Society Reviews, Journal Year: 2022, Volume and Issue: 52(1), P. 47 - 96
Published: Nov. 25, 2022
This review overviews the landscape of nanomedicine-aided cancer radio-immunotherapy in a “from bench to clinic” manner.
Language: Английский
Citations
47Drug Discovery Today, Journal Year: 2022, Volume and Issue: 27(6), P. 1622 - 1638
Published: March 21, 2022
Language: Английский
Citations
41